In this article, we are going to take a look at where Capricor Therapeutics, Inc. (NASDAQ:CAPR) stands against other worst high-risk high-reward growth stocks to buy. On March 14, Tom Lee managing ...

Teacher Retirement System of Texas acquired a new stake in Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC.

Capricor Therapeutics (CAPR) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.02 per share a year ago.

SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare ...

CAPR stock opened at $12.86 on Friday. Capricor Therapeutics has a one year low of $3.52 and a one year high of $23.40. The company’s fifty day moving average price is $14.06 and its 200-day ...

CAPRICOR THERAPEUTICS ($CAPR) posted quarterly earnings results on Wednesday, March 19th. The company reported earnings of -$0.16 per share, beating estimates of -$0. ...

Capricor Therapeutics (CAPR) released expectation-beating results for the fourth quarter, sending the shares up over 5% in aftermarket trading. This comes on the heels of the company achieving a ...

Capricor Therapeutics (CAPR) came out with a quarterly loss of ... For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain ...